Who owns Revolution Medicines, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RVMDW from SEC Form 13F filings across 22 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 22 institutions disclosed 10.1M shares of Revolution Medicines, Inc. worth $98.9M — about 4.8% of shares outstanding; the largest disclosed holder is LMR Partners LLP. Source: SEC Form 13F filings, parsed by EvidInvest.
22
13F holders
$98.9M
value, 2026 filers
4.8%
of shares outstanding (10.1M sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of RVMDW's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | LMR Partners LLP | 5.1M | $47.5M | 0.2% | 2.4% | +32.0% |
| 2 | D. E. Shaw & Co., Inc. | 1.6M | $14.9M | 0.0% | 0.7% | 0.0% |
| 3 | Sculptor Capital LP | 709,670 | $6.7M | 0.1% | 0.3% | -26.0% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 579,550 | $5,448 | 0.0% | 0.3% | 0.0% |
| 5 | Caption Management, LLC | 517,685 | $4.9M | 0.0% | 0.2% | 0.0% |
| 6 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $4.7M | 0.0% | 0.2% | 0.0% |
| 7 | PERCEPTIVE ADVISORS LLC | 250,000 | $2.3M | 0.0% | 0.1% | 0.0% |
| 8 | Bleichroeder LP | 200,000 | $1.9M | 0.3% | 0.1% | 0.0% |
| 9 | WOLVERINE ASSET MANAGEMENT LLC | 154,544 | $1.4M | 0.0% | 0.1% | -9.5% |
| 10 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 120,085 | $1.1M | 0.0% | 0.1% | 0.0% |
| 11 | Warberg Asset Management LLCNEW | 94,797 | $889,186 | 0.2% | 0% | new |
| 12 | CSS LLC/IL | 78,367 | $6.6M | 0.3% | 0% | +347.7% |
| 13 | DLK Investment Management, LLCNEW | 77,000 | $7,862 | 0.0% | 0% | new |
| 14 | Weiss Asset Management LP | 73,640 | $692,216 | 0.0% | 0% | 0.0% |
| 15 | TD Asset Management Inc | 40,636 | $381,978 | 0.0% | 0% | 0.0% |
| 16 | Rangeley Capital, LLCNEW | 25,000 | $4.7M | 4.3% | 0% | new |
| 17 | Driehaus Capital Management LLC | 20,000 | $188,000 | 0.0% | 0% | 0.0% |
| 18 | UBS Group AG | 2,461 | $23,084 | 0.0% | 0% | +177.8% |
| 19 | MORGAN STANLEY | 2,216 | $20,786 | 0.0% | 0% | 0.0% |
| 20 | TD Waterhouse Canada Inc. | 448 | $4,118 | 0.0% | 0% | 0.0% |
| 21 | ROYAL BANK OF CANADA | 200 | $2,000 | 0.0% | 0% | 0.0% |
| 22 | OSAIC HOLDINGS, INC. | 60 | $562 | 0.0% | 0% | -33.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.